Identify the genetic basis of myopathies
Subgroup Leader : Valérie BIANCALANA
We study rare and severe neuromuscular disorders caused by mutations in proteins controlling intracellular organization and dynamics. We aim to tackle the three main bottlenecks in this field:
.jpg)
Identify the genetic basis of myopathies, myalgia and high athletic performances
Project leaders : Valérie BIANCALANA, Johann BOHM, Jocelyn LAPORTE
Understand and cure myotubular/centronuclear myopathies through gene modulation and pharmacology
Project leader : Jocelyn LAPORTE
Understand and cure tubular aggregates myopathy and Stormorken syndrome through gene modulation and pharmacology
Project leader : Johann BOHM
Subgroup Leader : Valérie BIANCALANA
Subgroup Leader : Jocelyn LAPORTE
Article in a journal
Brain and Behavior ; Volume: 3 ; Page: 476-486
Article in a journal
FASEB Journal ; Volume: 27 ; Page: 3384-3394
Article in a journal
Journal of Cell Science ; Volume: 126 ; Page: 1806-19
Article in a journal
PLoS Genetics ; Volume: 9 ; Page: e1003583
Article in a journal
Acta Neuropathologica ; Volume: 125 ; Page: 173--185
Chapter of the book
Muscle Disease: Pathology and Genetics, Second edition ; Page: 134-144
Article in a journal
European Journal of Human Genetics ; Volume: 21 ; Page: 637-342
Article in a journal
PLoS ONE ; Volume: 8 ; Page: e67527
Article in a journal
PLoS Genetics ; Volume: 9, online ; Page: Non paginé
Article in a journal
American Journal of Human Genetics ; Volume: 92 ; Page: 271-278
Current fundings:

Her work, supervised by Dr. Jocelyn Laporte, is entitled "New Therapeutic Approaches for Neuromuscular Diseases."
Read more
On
12/102025
Follow our publications and latest research on Researchgate : www.researchgate.net/profile/Jocelyn-Laporte
Raw data for our study on Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies. Mol Ther. 2021 Apr 30:S1525-0016(21)00247-1.
www.ncbi.nlm.nih.gov/geo/query/acc.cgi
www.sciencedirect.com/science/article/abs/pii/S1525001621002471
In the press: